SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-22-000649
Accepted
2022-03-17 00:15:06
Documents
1
Effectiveness Date
2022-03-16
Registration Form
POS AM
Reference AccNo
0001493152-22-006504

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 610
  Complete submission text file 9999999995-22-000649.txt   1843
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: EFFECT | Act: 33 | File No.: 333-257104 | Film No.: 22746589
SIC: 2834 Pharmaceutical Preparations